19 May Cytotheryx

Cytotheryx is a preclinical cell therapy company focused on the development of a consistent, high-quality source of primary human hepatocytes and the application of those cells for multiple research and clinical applications. Primary human hepatocytes are currently used in toxicology studies, hepatitis research, and other liver-related disease research, but the limited supply restricts broader applications. Our foundational science will enable clinical applications, including liver assist devices, cell therapy, and ex vivo gene therapy. Initially, we will focus on partnering with pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and academic research institutions for the unregulated use of cells for research. Cytotheryx has the exclusive license to the patented technology out of Mayo Clinic. www.cytotheryx.com